SCHEMBL17550719

SCHEMBL17550719

Cc1ccccc1-c1cc(COc2ccc(S(=O)(=O)CC(=O)O)cc2)ccc1C

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17550664 0.91 FFAR1 (0.68) FFAR1
SCHEMBL17550703 0.80 FFAR1 (0.53) FFAR1
SCHEMBL28476384 0.80 FFAR1 (1.00) FFAR1
SCHEMBL19056850 0.75 FFAR1 (0.50) FFAR1
SCHEMBL28483239 0.71 FFAR1 (0.54) FFAR1
SCHEMBL7411076 0.71 KMT2A (0.63) FFAR1
SCHEMBL270706 0.69 MMP2 (0.77)
SCHEMBL28477386 0.68 FFAR1 (0.78) FFAR1
SCHEMBL19056859 0.68 FFAR1 (0.45) FFAR1
SCHEMBL28927514 0.68 FFAR1 (1.00) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3187488-B1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ HEALTHCARE CORP (KR) 2020-02-19 EP claimed
US-20170247320-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF CJ HEALTHCARE CORPORATION (KR) 2017-08-31 US claimed
EP-3187488-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ Healthcare Corporation (KR) 2017-07-05 EP claimed
EP-3187488-B1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ HEALTHCARE CORP (KR) 2020-02-19 EP disclosed
EP-3187488-B1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ HEALTHCARE CORP (KR) 2020-02-19 EP disclosed
US-20170247320-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF CJ HEALTHCARE CORPORATION (KR) 2017-08-31 US disclosed
US-20170247320-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF CJ HEALTHCARE CORPORATION (KR) 2017-08-31 US disclosed
US-20170247320-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF CJ HEALTHCARE CORPORATION (KR) 2017-08-31 US disclosed
EP-3187488-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ Healthcare Corporation (KR) 2017-07-05 EP disclosed
EP-3187488-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF CJ Healthcare Corporation (KR) 2017-07-05 EP disclosed
WO-2016032120-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVE AND USE THEREOF 씨제이헬스케어 주식회사 2016-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247320-A1 NOVEL AMINO-PHENYL-SULFONYL-ACETATE DERIVATIVES AND USE THEREOF SLC5A2, SLC5A1, IAPP FFAR1 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.